Analytical Technology Introductions Featured at Pittcon 2013
The Pittcon 2013 Exposition, which takes place Mar. 17–21, 2013, at the Pennsylvania Convention Center in Philadelphia, features emerging analytical technologies for analytical chemistry, drug discovery and development, nanotechnology, life sciences, and other disciplines. Instrument manufacturers frequently introduce new products or announce updates to current technologies at the event.

Waters Corp. Updates Instruments and Software
At Pittcon 2013, Water Corp. announced improvement to chromatography systems and software.

Thermo Fisher Scientific Introduces Software, Instruments, and Consumables
Thermo Fisher Scientific Inc. launched new software, instruments, consumables, and services for analytical applications at Pittcon 2013.

Shimadzu Scientific Instruments Adds Chromatography Instruments and Software
Shimadzu Scientific Instruments introduced several new products at Pittcon 2013, including chromatography instruments.

AstraZeneca to Cut 1600 Positions in R&D Reorganization
AstraZeneca announced that it will consolidate its R&D capabilities into three centers located in Cambridge, UK; Gaithersburg, MD in the US; and Sweden. The reorganization will result in a net loss of 1600 positions, mainly in the UK and the US.

INTERPOL and Pharma Collaborate to Fight Counterfeiting
INTERPOL and 29 of the world’s largest pharmaceutical companies have joined forces in an initiative to battle counterfeit drugs.

Advertisement: Tablet manufacturing problems? By partnering with Long Island University, Natoli Engineering has developed the Natoli Engineering Institute for Industrial Pharmacy Development and Research. Our mission is to provide customers with unique product solutions to their specific issues based on a combination of science and experience. Learn More!

More than 900 Biologics in Development
America’s biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report.

CDER Runs into Trouble with Generic Drug Reorg Plan
After less than a year on the job, the head of FDA’s Office of Generic Drugs (OGD) has announced his departure, a sign that all is not well with plans for major organizational changes at the Center for Drug Evaluation and Research (CDER).

Advertisement: Biotechnology Industry Organization Connect with 16,500 biotech professionals from 65 countries at the 2013 BIO International Convention in Chicago, April 22 – 25, for unparalleled partnering opportunities, expert insights and the latest technology discoveries. Choose from 125 targeted and timely education sessions. See the latest technology trends from 2,000+ leading suppliers and get a snapshot of global industry progress in 60+ state and country pavilions.Register now.

Advertisement: Dow Pharmaceutical Sciences Dermatologicals are unique. This NEW Dow 1–Day workshop will provide insightful answers to questions regarding formulation development or optimization, preclinical and clinical requirements, and regulatory strategies that are difficult to find. Speakers include Dow's Founder, Gordon Dow, one of the world's preeminent topical formulators. Dr. Jeffrey Sugarman will provide unique insights into a dermatologist's perspective on the relationship between skin disease and topical product development. www.dowpharmsci.com/topical-dermatological-product-development-seminar-2013

• The CDMO DPT Laboratories received notification from FDA on Feb. 19, 2013, that signaled the completion of the agency’s evaluation of DPT’s corrective actions taken at its Lakewood, New Jersey, facility in response to a Warning Letter received on Aug. 27, 2012.
• The International Pharmaceutical Excipients Council of the Americas (IPEC-Americas) has published the 2013 Excipient Information Package User Guide, which is now available for free download from the IPEC-Americas website.
• Micromeritics recently published its March 2013 microReport eNewsletter edition highlighting products, services, applications information, and upcoming events. New products include the 3Flex Surface Characterization Analyzer and Particluate Systems’ NanoPlus DLS Nano Particle Size and Zeta Potential Analyzer.
• The CMO Neuland Laboratories has formed a manufacturing collaboration with Tokyo-based API Corporation (APIC), a healthcare unit of Mitsubishi Chemical Holdings Group that produces APIs, intermediates, investigational new drugs, fine chemicals, and reagents.
• Read More